MicroRNA-196a & microRNA-101 expression in Barrett's oesophagus in patients with medically and surgically treated gastro-oesophageal reflux
<p>Abstract</p> <p>Background</p> <p>Proton pump inhibitor (PPI) medication and surgical fundoplication are used for the control of gastro-oesophageal reflux in patients with Barrett's oesophagus, but differ in their effectiveness for both acid and bile reflux. Thi...
Main Authors: | Bright Tim, Astill David, Leong Mary P, Watson David I, Haiart Sebastien, Hussey Damian J |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-02-01
|
Series: | BMC Research Notes |
Online Access: | http://www.biomedcentral.com/1756-0500/4/41 |
Similar Items
-
Barrett's oesophagus and oesophageal adenocarcinoma
by: Bird-Lieberman, E, et al.
Published: (2011) -
Long-term risk factors for developing Barrett’s oesophagus in patients with gastro-oesophageal reflux disease: a longitudinal cohort study
by: John F Dillon, et al.
Published: (2024-03-01) -
Epidemiology of Barrett’s oesophagus and oesophageal adenocarcinoma
by: Nancy Perez, et al.
Published: (2019-03-01) -
Combined Elevation of microRNA-196a and microRNA-196b in Sera Predicts Unfavorable Prognosis in Patients with Osteosarcomas
by: Chun Zhang, et al.
Published: (2014-04-01) -
THE CLONAL PROGRESSION OF BARRETT'S OESOPHAGUS TO OESOPHAGEAL ADENOCARCINOMA
by: Khan, S, et al.
Published: (2012)